Osteoporosis in Parkinson’s disease (PD) is an important issue for maintaining quality of life in patients with PD because osteoporosis is a risk factor of fracture. Bone metabolism is influenced by sex, age, nutrition and physical activity. Therefore, match-controlled studies of these influences are necessary to investigate the pathogenesis of osteoporosis in PD. In this study, we recruited 50 consecutive PD patients and sex- and age-matched 50 patients at the chronic stage of cerebrovascular disease (CVD) as disease controls who had the same body mass index and modified Rankin scale. Osteoporosis was evaluated with bone mineral density (BMD) and bone turnover markers. PD showed lower BMD, higher tartrate-resistant acid phosphatase 5b (TRACP) , higher total homocysteine and lower active vitamin D (VD) than CVD. Comparing between PD with osteoporosis and CVD with osteoporosis, PD with osteoporosis showed lower VD. Comparing between PD with and without osteoporosis, PD with osteoporosis showed female dominancy, lower body mass index, higher unified PD rating scale part IV, higher Hoehn and Yahr stage, higher type 1 collagen cross-linked N-telopeptide and TRACP. This study suggests that enhanced bone resorption, VD-mediating bone remodeling failure, and disease severity are evident in patients with osteoporosis in PD, excepting other known risks for osteoporosis.
View full abstract